Print

MiMedx Announces Record Third Quarter Results and Raises Revenue Estimates for the Year  
10/30/2012 9:27:08 AM

KENNESAW, Ga., Oct. 29, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2012.
//-->